Ref: PXL/H.O./CIR-075/2016-17 Date: 08.12.2016
Hyderabad
|
Symposium on
“Intellectual Property Rights (IPR) and Regulatory Perspective for Pharma & Biotech Sectors”
(Jointly organized by Pharmexcil and AIDCOC) coinciding 68thIndian Pharmaceutical Congress (IPC)-2016 17th December, 2016 at Andhra University Campus, Visakhapatnam
|
To
All the Members of Council
Dear Sir/Madam,
Subject: Symposium on “Intellectual Property Rights (IPR) and Regulatory Perspective for Pharma & Biotech Sectors” coinciding 68thIndian Pharmaceutical Congress (IPC)-2016 on 17th December, 2016 at Andhra University Campus, Visakhapatnam
We are glad to inform that Pharmexcil in association with All India Drug Control Officers (AIDCOC) is organizing Symposium on “Intellectual Property Rights (IPR) and Regulatory Perspective for Pharma & Biotech Sectors” coinciding 68th Indian Pharmaceutical Congress (IPC) on 17th December 2016 at Andhra University, Visakhapatnam, A.P.
Members are kindly aware Indian Pharmaceutical Congress is organizing its 68th edition with the theme “Quality Pharmaceuticals and Patient Welfare”. It is a dynamic forum, where thousands of professionals from Industry, Academics, Research institutes & Drugs control organizations assemble to meet, deliberate and recommend policy inputs to Govt. for growth of Pharma sector.
For more details of about IPC, kindly visit www.68ipc.com.
The Joint Symposium will have deliberations on the following topics succeeded by Panel discussion. The details of the programme is as follows:
Date:17th Dec, 2016
Time: 12:00 noon to 4.30 pm
|
Speaker
|
Title of the Topic
|
|
Dr. Manisha Shridhar, World Health Organization, Regional Office for South-East Asia (WHO/ SEARO)
|
"Networking of regulators in the South East Asia region for mutual cooperation for capacity building and skill development in Pharmaceuticals regulations."
|
|
Dr. Chava Satyanarayana, CEO - Laurus Labs Ltd
|
“Patents, Patients and Affordability”
|
|
Dr. Sanjit Singh Lamba, M.D. – Eisai Co. Ltd.
|
“Data Integrity – a paradigm shift in Regulators approach”
|
|
Mr. A.V. Jayapala Reddy,Global Head, Biologics, Hetero Labs Ltd.
|
Pharmaceutical Industry in Hyderabad and its contribution to IPR”
|
|
Dr.P.B.N.Prasad, DDC(I),CDSCO, Hyderabad
|
“Risk based Inspection an effective tool for Quality Management”
|
|
Panel Discussion
Panelists –
Dr.P.B.N.Prasad,DDC(I),CDSCO,Hyd.
Dr. Manisha Shridhar - WHO/ SEARO
Dr.Sanjit Singh Lamba, M.D. – Eisai Co.Ltd
Dr.Chava Satyanarayana, CEO - Laurus Labs Ltd
Dr.P.V.Appaji – Director General, Pharmexcil
Mr.Ravi Uday Bhaskar –Additional Executive Director – Pharmexcil & Secretary General - AIDCOC
|
Members are requested to take advantage of this opportunity and register your participation by sending email to biodesk@pharmexcil.com.
Registration:
No Registration fee.
For more information, please write to biodesk@pharmexcil.com
With regards,
Dr. P V Appaji
Director General
RSVP : Dr.Uma Vasireddy : 9440055209
|
